Nov. 11, 2022
The Data Science Institute (DSI) recently attended a two-day meeting at Pew Research Center in Washington D.C. The meeting was focused on discussing the results of the Pew Research Survey of the AI Landscape in Health Care. The DSI played an important role in this effort, serving as subject matter experts for the survey. 

The goal of the meeting was to create policy recommendations for the safe and effective use of AI in the healthcare industry. The results of the survey were presented and discussed by the attendees, including DSI CMO Dr. Allen, and Q&S and Informatics Commission Chairs Drs. Larson and Wald. The outcome of the meeting will be a paper that provides policy recommendations, including the importance of having an honest broker to evaluate AI algorithms for their safety and effectiveness. 

The DSI and ACR have demonstrated their expertise in the field of AI and their commitment to ensuring that the technology is used in a safe and effective manner in healthcare. The team's involvement in the Pew Research Survey and the subsequent policy recommendations will be an important step in advancing the use of AI in healthcare for the betterment of patients.

Related ACR News

  • Make America Healthy Again

    President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.

    Read more
  • Scope of Practice Bills Introduced At State Legislative Level

    The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.

    Read more
  • ACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint

    The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.

    Read more